Obesity Status among Breast Cancer Patients Based on the Korean Obesity Index Standard Reference in the Aging Community
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Obesity and age are known risk factors for breast cancer. However, as these factors tend to be reported together, their individual contributions are unclear; age might confound the impact of obesity on outcomes. This study investigated the status of obesity in patients with breast cancer and its correlation with either clinical characteristics or overall survival, using the Korean obesity index standard reference (KOISR) which stratified by age, and matched with outcomes of the local general population. Methods: We conducted a single-center retrospective study between January 2014 and December 2018. A total of 429 patients diagnosed with and treated for breast cancer were categorized according to the World Health Organization (WHO) body mass index (BMI) classification for Asian populations or KOISR. We examined the impact of the KOISR on the current status of obesity, and survival outcomes with the log-rank test. Results: In a sample of 418 patients, the distribution of obese, normal, and low BMI was 143 (34.2%), 266 (63.6%), and 9 (2.2%) patients, respectively. When categorized by the KOISR, 52.6% of all patients placed above the 75th percentile; advanced breast cancer diagnosis was likely in this group (p=0.030). BMI correlated with age (19.4% of women with less than 50 years and 45.4% of women aged 50 years and above were obese; p=0.001). No significant difference in overall survival (p=0.340) was observed between KOISR score-based groups (<75th percentile vs. ≥75th percentile), stratified by stage. Conclusion: Adjusted with a community and age (KOISR), patients with breast cancer have a relatively higher BMI than the general population in a similar community and generation. Women with a high KOISR score were also more likely to have advanced breast cancer than non-obese women. Nevertheless, high BMI was not a major factor affecting survival in this study.
Abstract
Purpose: Obesity and age are known risk factors for breast cancer. However, as these factors tend to be reported together, their individual contributions are unclear; age might confound the impact of obesity on outcomes. This study investigated the status of obesity in patients with breast cancer and its correlation with either clinical characteristics or overall survival, using the Korean obesity index standard reference (KOISR) which stratified by age, and matched with outcomes of the local general population. Methods: We conducted a single-center retrospective study between January 2014 and December 2018. A total of 429 patients diagnosed with and treated for breast cancer were categorized according to the World Health Organization (WHO) body mass index (BMI) classification for Asian populations or KOISR. We examined the impact of the KOISR on the current status of obesity, and survival outcomes with the log-rank test. Results: In a sample of 418 patients, the distribution of obese, normal, and low BMI was 143 (34.2%), 266 (63.6%), and 9 (2.2%) patients, respectively. When categorized by the KOISR, 52.6% of all patients placed above the 75th percentile; advanced breast cancer diagnosis was likely in this group (p=0.030). BMI correlated with age (19.4% of women with less than 50 years and 45.4% of women aged 50 years and above were obese; p=0.001). No significant difference in overall survival (p=0.340) was observed between KOISR score-based groups (<75th percentile vs. ≥75th percentile), stratified by stage. Conclusion: Adjusted with a community and age (KOISR), patients with breast cancer have a relatively higher BMI than the general population in a similar community and generation. Women with a high KOISR score were also more likely to have advanced breast cancer than non-obese women. Nevertheless, high BMI was not a major factor affecting survival in this study.
참고문헌 (30)
- Kim DM, "Prevalence of obesity in Korea", Obes Rev, 6, pp.117~121 (2005)
- Report on national health and nutrition survey 2001, "Korean Ministry of Health and Welfare", Korean Ministry of Health and Welfare, ~ (2002)
- Song HJ, "The impact of obesity and overweight on medical expenditures and disease incidence in Korea from 2002 to 2013", PLoS One, 13, pp.e0197057~ (2018)
- Kim YA, "Effects of obesity on breast cancer stage at diagnosis in Korean women", Eur J Cancer Prev, 13, pp.13~17 (2004)
- Picon-Ruiz M, "Interactions between adipocytes and breast cancer cells stimulate cytokine production and drive Src", Sox, Cancer Res, pp.2016, 76[DOI]
- Simone V, "Obesity and breast cancer : molecular interconnection and potential clinical applications", Oncologist, 21, pp.404~417 (2016)
- Niraula S, "Body size and breast cancer prognosis in relation to hormone receptor and menopausal status : a meta-analysis", Breast Cancer Res Treat, 134, pp.769~781 (2012)
- Chan DS, "Body mass index and survival in women with breast cancer : systemic literature review and meta-analysis of 82 follow-up studies", Ann Oncol, 25, pp.1901~1914 (2014)
- Keun-YoungYoo, "Epidemiology of Breast Cancer in Korea: Occurrence, High-Risk Groups, and Prevention", Journal of Korean Medical Science, 17(1), pp.1~6 (2002), 대한의학회
- Korean Breast Cancer Society, "Breast cancer facts & figures 2018", Korean Breast Cancer Society, ~ (2018)
- Report on national health and nutrition survey 1995, "Korean Ministry of Health and Welfare", Korean Ministry of Health and Welfare, ~ (1996)
- "Korean obesity index standard reference-v.1.2017" (2020)[URL]
- Kim YY, "Effects of the relative distribution of body mass index on the incidence of hypertension and diabetes mellitus, using the Korean obesity index", Metab Syndr Relat Disord, 17, pp.108~114 (2019)
- Kyung Hun Lee, "Body Mass Index Is Not Associated with Treatment Outcomes of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: Korean Data", Journal of Breast Cancer, 15(4), pp.427~433 (2012), 한국유방암학회[DOI]
- Chung IY, "Interaction between body mass index and hormone receptor status as a prognostic factor in lymph node –positive breast cancer", PLoS One, 12, pp.e0170311~ (2017)
- WHO expert consultation, "Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies", Lancet, 363, pp.157~163 (2004)
- Annual report of cancer statistics in Korea in 2016, , Ministry of Health and Walfare, ~ (2020)
- Chow LWC, "Association between body mass index and risk of formation of breast cancer in Chinese women", Asian J Surg, 28, pp.179~184 (2005)
- 강현석, "한국 여성에서 신체질량지수와 유방암 발생과의 관련성에 대한 연구", Journal of Breast Disease, 4(2), pp.64~69 (2016), 한국유방암학회[DOI]
- Park YM, "The association between metabolic health, obesity phenotype and the risk of breast cancer", Int J Cancer, 140, pp.2657~2666 (2017)
- Kim YA, "Effects of obesity on breast cancer stage at diagnosis in Korean women", Eur J Cancer Prev, 13, pp.13~17 (2004)
- Deglise C, "Impact of obesity on diagnosis and treatment of breast cancer", Breast Cancer Res Treat, 120, pp.185~193 (2010)
- Cui Y, "Body mass and stage of breast cancer at diagnosis", Int J Cancer, 98, pp.279~283 (2002)
- Goodwin PJ, "Obesity and endocrine therapy : host factors and breast cancer outcome", Breast, 22, pp.S44~7 (2013)
- Wang X, "Body mass index at diagnosis as a prognostic factor for early-stage invasive breast cancer after surgical resection", Oncol Res Treat, 42, pp.190~196 (2019)
- Seynaeve C, "The impact of body mass index on the efficacy of adjuvant endocrine therapy in postmenopausal hormone sensitive breast cancer patients: exploratory analysis from the TEAM study", Cancer Res, 70, pp.S2~S3 (2010)
- Kamineni A, "Body mass index, tumor characteristics, and prognosis following diagnosis of early-stage breast cancer in a mammographically screened population", Cancer Causes Control, 24, pp.305~312 (2013)
- Dignam JJ, "Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer", J Natl Cancer Inst, 95, pp.1467~1476 (2003)
- Robinson PJ, "Obesity is associated with a poorer prognosis in women with hormone receptor positive breast cancer", Maturitas, 79, pp.279~286 (2014)
- Gennari A, "Impact of body mass index(BMI)on the prognosis of high-risk early breast cancer(EBC)patients treated with adjuvant chemotherapy", Breast Cancer Res Treat, 159, pp.79~86 (2016)